Mankind Pharma to buy Combihale, Daffy brands from Dr Reddys

Published On 2022-02-17 12:19 GMT   |   Update On 2022-02-17 12:19 GMT

Mankind Pharma on Wednesday said it has inked a pact with Dr Reddy's Laboratories to acquire two brands -- Combihale and Daffy. While Combihale is used for the treatment of asthma and chronic obstructive pulmonary disease, Daffy is a soap-free moisturising bar for infants. Mankind Pharma said the market for Combihale is valued at Rs 900 crore growing at 14 per cent.For more information check...

Login or Register to read the full article

Mankind Pharma on Wednesday said it has inked a pact with Dr Reddy's Laboratories to acquire two brands -- Combihale and Daffy. While Combihale is used for the treatment of asthma and chronic obstructive pulmonary disease, Daffy is a soap-free moisturising bar for infants.

Mankind Pharma said the market for Combihale is valued at Rs 900 crore growing at 14 per cent.

For more information check out the full story on the link below:  

Dr Reddys To Sell Two Brands, Combihal And Daffy To Mankind Pharma 

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News